Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun 27:5:75.
doi: 10.3389/fcvm.2018.00075. eCollection 2018.

Peguero Electrocardiographic Left Ventricular Hypertrophy Criteria and Risk of Mortality

Affiliations

Peguero Electrocardiographic Left Ventricular Hypertrophy Criteria and Risk of Mortality

Hesham M A Afify et al. Front Cardiovasc Med. .

Abstract

Background: Peguero electrocardiographic left ventricular hypertrophy (ECG-LVH) criteria are newly developed criteria that have shown better diagnostic performance than the traditional Cornell-voltage and Sokolow-Lyon criteria. However, prediction of poor outcomes rather than detection of increased left ventricular mass is becoming the primary use for ECG-LVH criteria which requires investigating any new ECG-LVH criteria in terms of prediction. Aims: To examine the prognostic significance of the newly developed Peguero ECG-LVH criteria. Methods: We compared the prognostic significance of Peguero ECG-LVH with Cornell-voltage and Sokolow-Lyon ECG-LVH criteria in 7,825 participants (age 59.8 ± 13.4 years; 52.7% women) from the third National Health and Nutrition Examination Survey who were free of major intraventricular conduction defects. ECG-LVH criteria were derived from digital ECG tracings processed at a central core laboratory. Results: At baseline, ECG-LVH was detected in 11.8% by Peguero; in 4.3% by Cornell voltage and in 6.4% by Sokolow-Lyon. During a median follow up of 13.8 years, 2,796 all-cause mortality events occurred. In multivariable models adjusted for demographics and cardiovascular risk factors, presence of Peguero ECG-LVH was associated with increased risk of all-cause mortality [HR (95% CI): 1.29 (1.16, 1.44)]. This association was not significantly different from the associations of Cornell voltage-LVH or Sokolow-Lyon LVH with all-cause mortality [HR (95%CI): 1.32 (1.12, 1.55) and 1.24 (1.07, 1.43), respectively; p-values for comparisons of these HRs with the HR of Peguero ECG-LVH 0.817 and 0.667, respectively]. Similar patterns of associations were observed with cardiovascular, ischemic heart disease and heart failure mortalities. Conclusion: Peguero ECG-LVH is predictive of increased risk of death similar to the traditional ECG-LVH criteria.

Keywords: ECG-LVH; NHANES-III; Peguero ECG-LVH criteria; electrocardiogram; prognostic performance.

PubMed Disclaimer

Figures

Figure 1
Figure 1
This figure shows the survival probability plot for all-cause mortality by ECG-LVH status.

References

    1. Rider OJ, Ntusi N, Bull SC, Nethononda R, Ferreira V, Holloway CJ, et al. . Improvements in ECG accuracy for diagnosis of left ventricular hypertrophy in obesity. Heart (2016) 102:1566–72. 10.1136/heartjnl-2015-309201 - DOI - PMC - PubMed
    1. Rautaharju PM, Soliman EZ. Electrocardiographic left ventricular hypertrophy and the risk of adverse cardiovascular events: a critical appraisal. J Electrocardiol. (2014) 47:649–54. 10.1016/j.jelectrocard.2014.06.002 - DOI - PubMed
    1. Oseni AO, Qureshi WT, Almahmoud MF, Bertoni AG, Bluemke DA, Hundley WG, et al. . Left ventricular hypertrophy by ECG versus cardiac MRI as a predictor for heart failure. Heart (2017) 103:49–54. 10.1136/heartjnl-2016-309516 - DOI - PMC - PubMed
    1. Almahmoud MF, O'Neal WT, Qureshi W, Soliman EZ. Electrocardiographic versus echocardiographic left ventricular hypertrophy in prediction of congestive heart failure in the elderly. Clin Cardiol. (2015) 38:365–70. 10.1002/clc.22402 - DOI - PMC - PubMed
    1. O'Neal WT, Almahmoud MF, Qureshi WT, Soliman EZ. Electrocardiographic and echocardiographic left ventricular hypertrophy in the prediction of stroke in the elderly. J Stroke Cerebrovasc Dis. (2015) 24:1991–7. 10.1016/j.jstrokecerebrovasdis.2015.04.044 - DOI - PMC - PubMed

LinkOut - more resources